Page last updated: 2024-11-07

spironolactone and Extramembranous Glomerulopathy

spironolactone has been researched along with Extramembranous Glomerulopathy in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuriyama, S1
Sugano, N1
Ueda, H1
Otsuka, Y1
Kanzaki, G1
Hosoya, T1
LIEBERMAN, ME1

Other Studies

2 other studies available for spironolactone and Extramembranous Glomerulopathy

ArticleYear
Successful effect of triple blockade of renin-angiotensin-aldosterone system on massive proteinuria in a patient with chronic kidney disease.
    Clinical and experimental nephrology, 2009, Volume: 13, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Eplerenone; Glome

2009
MEMBRANOUS GLOMERULONEPHRITIS: DISCUSSION AND CASE PRESENTATION.
    The Journal of the American Osteopathic Association, 1964, Volume: 63

    Topics: Adolescent; Adrenocorticotropic Hormone; Biopsy; Cortisone; Diagnosis; Electrons; Glomerulonephritis

1964